MBX Biosciences Inc (NAS:MBX)
$ 62.08 -1.57 (-2.47%) Market Cap: 2.95 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 6.75 GF Score: 12/100

MBX Biosciences Inc at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 02:10 PM GMT
Release Date Price: $32.97 (+1.29%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MBX.OQ - MBX Biosciences Inc
MBX Biosciences Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 02:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Right, good morning, everyone.

Thank you very much for being here. It's a pleasure to welcome you to TD Cowan's forty-sixth annual healthcare conference. My name's Tyler Van Buren. I'm a senior biotech analyst here at TD Cowan. And for next session, the first, company session of the day, we're very pleased to have a hybrid presentation and Fireside chat style Q&A with MBX Biosciences, and it's my pleasure to introduce Kent Harlock, the President and CEO of MBX, and SAM Azoula, the Chief Medical Officer. It's a privilege to have you both here. I'll hand it over to you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot